EP3749298
INHALABLE DRY POWDER CYTIDINE ANALOGUE COMPOSITION AND METHOD OF USE AS A TREATMENT FOR CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
7.2.2019EP published:
5.4.2023EP application number:
19751123.1
EPO information:
European Patent Register
Max expiry date:
6.2.2039
Title in English:
INHALABLE DRY POWDER CYTIDINE ANALOGUE COMPOSITION AND METHOD OF USE AS A TREATMENT FOR CANCERLanguage of the patent:
English
Timeline
Today
7.2.2019EP application
5.4.2023EP Publication
Owner
Name:
Lovelace Biomedical Research InstituteAddress:
2425 Ridgecrest Drive, S.E., Albuquerque, New Mexico 87108, US
Inventor
Name:
BELINSKY, Steven A.Address:
Albuquerque, New Mexico 87108, US
Name:
KUEHL, Philip J.Address:
Albuquerque, New Mexico 87108, US
Name:
BADENOCH, AaronAddress:
Bend, Oregon 97701, US
Name:
BURKE, MichaelAddress:
Bend, Oregon 97701, US
Name:
DUBOSE, DevonAddress:
Bend, Oregon 97701, US
Priority
Number:
201862627428 PDate:
7.2.2018Country:
US
Classification
Categories:
A61K 9/00, A61K 31/282, A61K 31/706, A61K 9/14, A61K 47/18, A61K 47/26, A61P 35/00